Zobrazeno 1 - 10
of 168
pro vyhledávání: '"Denis Y, Logunov"'
Autor:
Daria V. Vasina, Nataliia P. Antonova, Vladimir A. Gushchin, Andrey V. Aleshkin, Mikhail V. Fursov, Anastasiia D. Fursova, Petya G. Gancheva, Igor V. Grigoriev, Pavel Grinkevich, Alexey V. Kondratev, Alexey V. Kostarnoy, Anastasiya M. Lendel, Valentine V. Makarov, Maria A. Nikiforova, Andrei A. Pochtovyi, Tatiana Prudnikova, Timofey A. Remizov, Natalia V. Shevlyagina, Andrei E. Siniavin, Nina S. Smirnova, Alexander A. Terechov, Artem P. Tkachuk, Evgeny V. Usachev, Aleksei M. Vorobev, Victoria S. Yakimakha, Sergey M. Yudin, Anastasia A. Zackharova, Vladimir G. Zhukhovitsky, Denis Y. Logunov, Alexander L. Gintsburg
Publikováno v:
Journal of Biomedical Science, Vol 31, Iss 1, Pp 1-21 (2024)
Abstract Background Among the non-traditional antibacterial agents in development, only a few targets critical Gram-negative bacteria such as carbapenem-resistant Pseudomonas aeruginosa, Acinetobacter baumannii or cephalosporin-resistant Enterobacter
Externí odkaz:
https://doaj.org/article/ee3203824f7d4295bd76986e489516e6
Autor:
Elena P. Mazunina, Vladimir A. Gushchin, Evgeniia N. Bykonia, Denis A. Kleymenov, Andrei E. Siniavin, Sofia R. Kozlova, Evgenya A. Mukasheva, Elena V. Shidlovskaya, Nadezhda A. Kuznetsova, Evgeny V. Usachev, Vladimir I. Zlobin, Elena I. Burtseva, Roman A. Ivanov, Denis Y. Logunov, Alexander L. Gintsburg
Publikováno v:
Vaccines, Vol 12, Iss 11, p 1206 (2024)
Background. The combined or multivalent vaccines are actively used in pediatric practice and offer a series of advantages, including a reduced number of injections and visits to the doctor, simplicity of the vaccination schedule and minimization of s
Externí odkaz:
https://doaj.org/article/020ec846bd364403b1b20c1353873e8e
Autor:
Inna V. Dolzhikova, Amir I. Tukhvatulin, Daria M. Grousova, Ilya D. Zorkov, Marina E. Komyakova, Anna A. Ilyukhina, Anna V. Kovyrshina, Artem Y. Shelkov, Andrey G. Botikov, Ekaterina G. Samokhvalova, Dmitrii A. Reshetnikov, Andrey E. Siniavin, Daria M. Savina, Dmitrii V. Shcheblyakov, Fatima M. Izhaeva, Alina S. Dzharullaeva, Alina S. Erokhova, Olga Popova, Tatiana A. Ozharovskaya, Denis I. Zrelkin, Polina P. Goldovskaya, Alexander S. Semikhin, Olga V. Zubkova, Andrey A. Nedorubov, Vladimir A. Gushchin, Boris S. Naroditsky, Denis Y. Logunov, Alexander L. Gintsburg
Publikováno v:
Vaccines, Vol 12, Iss 10, p 1152 (2024)
Background: The SARS-CoV-2 virus continuously acquires mutations, leading to the emergence of new variants. Notably, the effectiveness of global vaccination efforts has significantly declined with the rise and spread of the B.1.1.529 (Omicron) varian
Externí odkaz:
https://doaj.org/article/5ca4e161630e45b996f7587289d1a662
Autor:
Elena P. Mazunina, Vladimir A. Gushchin, Denis A. Kleymenov, Andrei E. Siniavin, Elena I. Burtseva, Maksim M. Shmarov, Evgenya A. Mukasheva, Evgeniia N. Bykonia, Sofia R. Kozlova, Elina A. Evgrafova, Anastasia N. Zolotar, Elena V. Shidlovskaya, Elena S. Kirillova, Anastasiya S. Krepkaia, Evgeny V. Usachev, Nadezhda A. Kuznetsova, Igor A. Ivanov, Sergey E. Dmitriev, Roman A. Ivanov, Denis Y. Logunov, Alexander L. Gintsburg
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Seasonal influenza remains a serious global health problem, leading to high mortality rates among the elderly and individuals with comorbidities. Vaccination is generally accepted as the most effective strategy for influenza prevention. While current
Externí odkaz:
https://doaj.org/article/5436628e6d8743ce9fa3eedb426fd822
Autor:
Evgeniia N. Bykonia, Denis A. Kleymenov, Vladimir A. Gushchin, Andrei E. Siniavin, Elena P. Mazunina, Sofia R. Kozlova, Anastasia N. Zolotar, Evgeny V. Usachev, Nadezhda A. Kuznetsova, Elena V. Shidlovskaya, Andrei A. Pochtovyi, Daria D. Kustova, Igor A. Ivanov, Sergey E. Dmitriev, Roman A. Ivanov, Denis Y. Logunov, Alexander L. Gintsburg
Publikováno v:
Vaccines, Vol 12, Iss 4, p 379 (2024)
SARS-CoV-2 variants have evolved over time in recent years, demonstrating immune evasion of vaccine-induced neutralizing antibodies directed against the original S protein. Updated S-targeted vaccines provide a high level of protection against circul
Externí odkaz:
https://doaj.org/article/03abaa964fc548d6a9bb5f7b5f2b23ba
Autor:
Daria S. Fomina, Marina S. Lebedkina, Anna A. Iliukhina, Anna V. Kovyrshina, Artem Y. Shelkov, Sergey S. Andreev, Anton A. Chernov, Inna V. Dolzhikova, Tatyana S. Kruglova, Gerelma V. Andrenova, Amir I. Tukhvatulin, Dmitry V. Shcheblyakov, Alexander V. Karaulov, Maryana A. Lysenko, Denis Y. Logunov, Alexander L. Gintsburg
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Several virus-neutralizing monoclonal antibodies (mAbs) have become new tools in the treatment of the coronavirus disease (COVID-19), but their effectiveness against the rapidly mutating virus is questionable. The present study investigated the effec
Externí odkaz:
https://doaj.org/article/670820e7fe5d4672ba2d2ca795a32834
Autor:
Amir I. Tukhvatulin, Ilya V. Gordeychuk, Inna V. Dolzhikova, Alina S. Dzharullaeva, Marina E. Krasina, Ekaterina O. Bayurova, Daria M. Grousova, Anna V. Kovyrshina, Alla S. Kondrashova, Daria V. Avdoshina, Stanislav A. Gulyaev, Tatiana V. Gulyaeva, Andrey V. Moroz, Viktoria V. Illarionova, Ilya D. Zorkov, Anna A. Iliukhina, Artem Y. Shelkov, Andrei G. Botikov, Alina S. Erokhova, Dmitry V. Shcheblyakov, Ilias B. Esmagambetov, Olga V. Zubkova, Elisaveta A. Tokarskaya, Daria M. Savina, Yulia R. Vereveyko, Anastasiya S. Ungur, Boris S. Naroditsky, Aydar A. Ishmukhametov, Denis Y. Logunov, Alexander L. Gintsburg
Publikováno v:
Emerging Microbes and Infections, Vol 11, Iss 1, Pp 2229-2247 (2022)
Although unprecedented efforts aiming to stop the COVID-19 pandemic have been made over the past two years, SARSCoV-2 virus still continues to cause intolerable health and economical losses. Vaccines are considered the most effective way to prevent i
Externí odkaz:
https://doaj.org/article/8a8e17e744c744cc8415e7fd4b98dfbe
Autor:
Amir I. Tukhvatulin, Inna V. Dolzhikova, Alina S. Dzharullaeva, Daria M. Grousova, Anna V. Kovyrshina, Olga V. Zubkova, Ilya D. Zorkov, Anna A. Iliukhina, Artem Y. Shelkov, Alina S. Erokhova, Olga Popova, Tatiana A. Ozharovskaia, Denis I. Zrelkin, Fatima M. Izhaeva, Dmitry V. Shcheblyakov, Ilias B. Esmagambetov, Elisaveta A. Tokarskaya, Natalia A. Nikitenko, Nadezhda L. Lubenets, Elizaveta A. Khadorich, Vladimir A. Gushchin, Svetlana N. Borzakova, Anna V. Vlasova, Ismail M. Osmanov, Valerii V. Gorev, Boris S. Naroditsky, Denis Y. Logunov, Alexander L. Gintsburg
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
To protect young individuals against SARS-CoV-2 infection, we conducted an open-label, prospective, non-randomised dose-escalation Phase 1/2 clinical trial to evaluate the immunogenicity and safety of the prime-boost “Sputnik V” vaccine administe
Externí odkaz:
https://doaj.org/article/eccefe49c05d44c496a720e9225bf865
Autor:
Elizaveta S. Darnotuk, Andrei E. Siniavin, Natal’ya S. Shastina, Sergey I. Luyksaar, Anna M. Inshakova, Natalia E. Bondareva, Sergey A. Zolotov, Nadezhda L. Lubenec, Anna B. Sheremet, Denis Y. Logunov, Nailya A. Zigangirova, Vladimir A. Gushchin, Alexander L. Gintsburg
Publikováno v:
Pharmaceuticals, Vol 17, Iss 1, p 35 (2023)
The spread of COVID-19 infection continues due to the emergence of multiple transmissible and immune-evasive variants of the SARS-CoV-2 virus. Although various vaccines have been developed and several drugs have been approved for the treatment of COV
Externí odkaz:
https://doaj.org/article/145647bfa7264703919cf346a03d2fd3
Autor:
Ilias B. Esmagambetov, Ekaterina I. Ryabova, Artem A. Derkaev, Dmitry V. Shcheblyakov, Inna V. Dolzhikova, Irina A. Favorskaya, Daria M. Grousova, Mikhail A. Dovgiy, Vladimir V. Prokofiev, Andrey I. Gosudarev, Daria V. Byrikhina, Ilia D. Zorkov, Anna A. Iliukhina, Anna V. Kovyrshina, Artem Y. Shelkov, Boris S. Naroditsky, Denis Y. Logunov, Alexander L. Gintsburg
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionNumerous agents for prophylaxis of SARS-CoV-2-induced diseases are currently registered for the clinical use. Formation of the immunity happens within several weeks following vaccine administration which is their key disadvantage. In cont
Externí odkaz:
https://doaj.org/article/435734489115452892c1fe539af6307b